QQ客服 官方微博 反馈留言

浏览/检索结果: 共6条，第1-6条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择发表日期升序发表日期降序提交时间升序提交时间降序题名升序题名降序作者升序作者降序 Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial 期刊论文 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 卷号: 73, 期号: 4 作者:  Szarek, Michael;  White, Harvey D.;  Schwartz, Gregory G.;  Alings, Marco;  Bhatt, Deepak L. 收藏  |  浏览/下载：131/0  |  提交时间：2019/12/05 acute coronary syndrome  alirocumab  total events   Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal Events The ODYSSEY OUTCOMES Trial 期刊论文 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 卷号: 73, 期号: 4, 页码: 387-396 作者:  Szarek, Michael;  White, Harvey D.;  Schwartz, Gregory G.;  Alings, Marco;  Bhatt, Deepak L. 收藏  |  浏览/下载：31/0  |  提交时间：2019/12/11 acute coronary syndrome  alirocumab  total events   Alirocumab in Patients With Polyvascular Disease and Recent Acute Coronary Syndrome ODYSSEY OUTCOMES Trial 期刊论文 JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 卷号: 74, 期号: 9, 页码: 1167-1176 作者:  Jukema, J. Wouter;  Szarek, Michael;  Zijlstra, Laurien E.;  de Silva, H. Asita;  Bhatt, Deepak L. 收藏  |  浏览/下载：27/0  |  提交时间：2019/12/11 acute coronary syndrome  alirocumab  cerebrovascular disease  death  major adverse cardiac events  peripheral artery disease   Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial 期刊论文 LANCET DIABETES & ENDOCRINOLOGY, 2019, 卷号: 7, 期号: 8, 页码: 618-628 作者:  Ray, Kausik K.;  Colhoun, Helen M.;  Szarek, Michael;  Baccara-Dinet, Marie;  Bhatt, Deepak L. 收藏  |  浏览/下载：22/0  |  提交时间：2019/12/11 Effects of alirocumab on types of myocardial infarction: insights from the ODYSSEY OUTCOMES trial 期刊论文 EUROPEAN HEART JOURNAL, 2019, 卷号: 40, 期号: 33, 页码: 2801-2809 作者:  White, Harvey D.;  Steg, Ph. Gabriel;  Szarek, Michael;  Bhatt, Deepak L.;  Bittner, Vera A. 收藏  |  浏览/下载：24/0  |  提交时间：2019/12/11 Alirocumab  Prevention  MI types  Mortality   Effect of Alirocumab on Mortality After Acute Coronary Syndromes An Analysis of the ODYSSEY OUTCOMES Randomized Clinical Trial 期刊论文 CIRCULATION, 2019, 卷号: 140, 期号: 2, 页码: 103-112 作者:  Steg, Philippe Gabriel;  Szarek, Michael;  Bhatt, Deepak L.;  Bittner, Vera A.;  Bregeault, Marie-France 收藏  |  浏览/下载：28/0  |  提交时间：2019/12/11 acute coronary syndrome  alirocumab  cholesterol  mortality  PCSK9  protein